These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 34522594)

  • 21. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
    Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
    Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing Linker Chain Length and Intestinal Stability Enhances Lymphatic Transport and Lymph Node Exposure of Triglyceride Mimetic Prodrugs of a Model Immunomodulator Mycophenolic Acid.
    Han S; Quach T; Hu L; Lim SF; Zheng D; Leong NJ; Sharma G; Bonner D; Simpson JS; Trevaskis NL; Porter CJH
    Mol Pharm; 2023 May; 20(5):2675-2685. PubMed ID: 36996486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles.
    Sahin A; Spiroux F; Guedon I; Arslan FB; Sarcan ET; Ozkan T; Colak N; Yuksel S; Ozdemir S; Ozdemir B; Akbas S; Ultav G; Aktas Y; Capan Y
    Pharmazie; 2017 Sep; 72(9):525-528. PubMed ID: 29441979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination.
    Fievez V; Plapied L; des Rieux A; Pourcelle V; Freichels H; Wascotte V; Vanderhaeghen ML; Jerôme C; Vanderplasschen A; Marchand-Brynaert J; Schneider YJ; Préat V
    Eur J Pharm Biopharm; 2009 Sep; 73(1):16-24. PubMed ID: 19409989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient Intestinal Digestion and On Site Tumor-Bioactivation are the Two Important Determinants for Chylomicron-Mediated Lymph-Targeting Triglyceride-Mimetic Docetaxel Oral Prodrugs.
    Tian C; Guo J; Wang G; Sun B; Na K; Zhang X; Xu Z; Cheng M; He Z; Sun J
    Adv Sci (Weinh); 2019 Dec; 6(24):1901810. PubMed ID: 31871861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
    Cho HJ; Park JW; Yoon IS; Kim DD
    Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development.
    Brocks DR; Davies NM
    J Pharm Pharm Sci; 2018; 21(1s):254s-270s. PubMed ID: 30348249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
    Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E
    Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
    Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
    J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery.
    Wu T; Gong Y; Li Z; Li Y; Xiong X
    Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes.
    McCright J; Skeen C; Yarmovsky J; Maisel K
    Acta Biomater; 2022 Jun; 145():146-158. PubMed ID: 35381399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
    Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
    Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration.
    Dou J; Zhang H; Liu X; Zhang M; Zhai G
    Colloids Surf B Biointerfaces; 2014 Feb; 114():20-7. PubMed ID: 24157590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-emulsifying Drug Delivery System Improve Oral Bioavailability: Role of Excipients and Physico-chemical Characterization.
    Zhu Y; Ye J; Zhang Q
    Pharm Nanotechnol; 2020; 8(4):290-301. PubMed ID: 32781978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
    Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
    Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs.
    Mao Y; Feng S; Li S; Zhao Q; Di D; Liu Y; Wang S
    Biomaterials; 2019 Jan; 188():173-186. PubMed ID: 30359884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.